Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 3Withdrawn 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 23Prostatic Neoplasms 12Lymphoma 11Burkitt Lymphoma 9Lymphoma, Large B-Cell, Diffuse 4Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Dendritic Cell Sarcoma, Interdigitating 3Anemia, Refractory, with Excess of Blasts 3Recurrence 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Anemia, Refractory 2Stomatitis 1Rhabdoid Tumor 1Pituitary Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Oral Ulcer 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1

Interventions

Cytarabine 272Cyclophosphamide 136fludarabine phosphate 127Azacitidine 117Peripheral Blood Stem Cell Transplantation 95Busulfan 93Filgrastim 80Decitabine 79fludarabine 78Mycophenolic Acid 78Idarubicin 76Etoposide 76Whole-Body Irradiation 75Daunorubicin 72Tacrolimus 71Cyclosporine 64Methotrexate 62Mitoxantrone 57Clofarabine 55Antilymphocyte Serum 55Granulocyte Colony-Stimulating Factor 51Gemtuzumab 50Melphalan 49venetoclax 48Radiotherapy 30sargramostim 28Injections 25Bortezomib 25thymoglobulin 24aldesleukin 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Acute × Hydrocortisone × Clear all
NCT03813147 2025-04-13

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled 16 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02270788 2017-10-03

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 1 Completed
10 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00005802 2010-04-02

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 1/2 Completed
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡